These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31587246)

  • 1. Prevalence of Antiphospholipid Antibodies Negativisation in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Multicentre Study.
    Radin M; Schreiber K; Sciascia S; Roccatello D; Cecchi I; Aguirre Zamorano MÁ; Cuadrado MJ
    Thromb Haemost; 2019 Dec; 119(12):1920-1926. PubMed ID: 31587246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.
    Tarr T; Lakos G; Bhattoa HP; Soltesz P; Shoenfeld Y; Szegedi G; Kiss E
    Clin Rev Allergy Immunol; 2007 Apr; 32(2):131-7. PubMed ID: 17916982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.
    Mekinian A; Alijotas-Reig J; Carrat F; Costedoat-Chalumeau N; Ruffatti A; Lazzaroni MG; Tabacco S; Maina A; Masseau A; Morel N; Esteve-Valverde EE; Ferrer-Oliveras R; Andreoli L; De Carolis S; Josselin-Mahr L; Abisror N; Nicaise-Roland P; Tincani A; Fain O;
    Autoimmun Rev; 2017 Jul; 16(7):730-734. PubMed ID: 28478081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity.
    Pyo JY; Jung SM; Lee SW; Song JJ; Lee SK; Park YB
    Yonsei Med J; 2017 Nov; 58(6):1128-1134. PubMed ID: 29047236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome.
    Udry S; Latino JO; Belizna C; Perés Wingeyer S; Fernández Romero DS; de Larrañaga G
    Immunol Res; 2019 Dec; 67(6):478-485. PubMed ID: 31873844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid syndrome.
    Cervera R
    Thromb Res; 2017 Mar; 151 Suppl 1():S43-S47. PubMed ID: 28262233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion?
    Sciascia S; Coloma-Bazán E; Radin M; Bertolaccini ML; López-Pedrera C; Espinosa G; Meroni PL; Cervera R; Cuadrado MJ
    Autoimmun Rev; 2017 Nov; 16(11):1109-1114. PubMed ID: 28899804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence.
    Medina G; Briones-García E; Cruz-Domínguez MP; Flórez-Durante OI; Jara LJ
    Autoimmun Rev; 2017 Apr; 16(4):352-354. PubMed ID: 28216071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion.
    Zen M; Loredo Martinez M; Benvenuti F; Gatto M; Saccon F; Larosa M; Iaccarino L; Doria A
    Rheumatology (Oxford); 2021 Mar; 60(3):1313-1320. PubMed ID: 32940703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative.
    Coloma Bazán E; Donate López C; Moreno Lozano P; Cervera R; Espinosa G
    Immunol Res; 2013 Jul; 56(2-3):358-61. PubMed ID: 23568055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological evolution in women with positive antiphospholipid antibodies.
    Riancho-Zarrabeitia L; Daroca G; Muñoz P; López-Hoyos M; Haya A; Martínez-Taboada VM
    Semin Arthritis Rheum; 2017 Dec; 47(3):397-402. PubMed ID: 28576307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
    Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
    Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.